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Summary This study describes the effect of intratracheal instillations (2 x 5mg) of benzo(a)pyrene (B(a)P) on
lung carcinogenesis in rats which had previously inhaled different levels of 239 plutonium oxide (220, 630,
6300Bq, initial lung burden). Survival decreased with increasing PuO2 exposure and additional B(a)P
exposure. The incidence of malignant lung tumours, adjusted for differences in survival, increased in a dose-
related fashion with PuO2 dose and was elevated in the presence of additional B(a)P exposure. A
multiplicative relative risk model was found to describe reasonably well the observed joint effect. The
practical implications of these findings are discussed.
A dose-response relationship between inhaled
239PuO2 and the induction of lung tumours in rats
and dogs is now well known for initial lung
burdens higher than 180 Bq (5nCi) (Bair &
Thomas, 1975; Dagle et al., 1980; Lafuma et al.,
1974; Sanders et al., 1976; Sanders & Mahaffey,
1979). However, there is still very little information
on the possible synergistic effects of 239PuO2
particles and environmental chemical carcinogens.
Benzo(a)pyrene [B(a)P], a polycyclic aromatic
hydrocarbon, which is formed in several
environmental situations has been shown to be a
potent animal carcinogen; however, its role in the
induction of lung cancer in humans although
strongly suspected, has not yet been conclusively
established (Farber, 1982; IARC, 1983). The
combined effect of an a-emitter and cigarette
smoke has been investigated in both experimental
animals and epidemiological studies (Chameaud
et al., 1980; Whittemore & McMillan, 1983; Little
et al., 1970). In the same vein, the experiment
described in this paper involved joint exposure to
239PuO2, another cx-emitter, and B(a)P, a major
component of tobacco smoke and of incomplete
combustion of coal and other fossil fuels.
Inhalation or intratracheal instillation of B(a)P
induced lung tumours (mainly squamous-cell
carcinomas) in several animal species (Saffiotti
et al., 1972a,b; Preussmann, 1976; Farber, 1982).
In an early experiment, Temple et al. (1960)
reported an increase of the incidence of Pu-induced
tumours by the additional administration of
methylcholanthrene and dibenzanthracene, two
polycyclic aromatic hydrocarbons. However, their
results are very difficult to evaluate quantitatively.
Sanders (1973) reported an additive effect on the
induction of abdominal sarcomas after
intraperitoneal injections of PuO2 and B(a)P. In a
preliminary experiment (Metivier et al., 1979), we
showed that B(a)P can increase the severity of the
observed lesions in rats inhaling large doses of
plutonium (6300 Bq) but does not modify the
survival time observed with plutonium alone. That
experiment has been expanded to include two lower
dose levels of plutonium (630Bq and 220Bq) and
more control animals. A full analysis of this
experiment is presented here, with particular
emphasis on the joint effect of 239PuO2 and B(a)P
on the incidence of lung tumours.
Experimental methods
Random bred, 2-month-old, male SPF Wistar rats,
weighing 200-220g at the beginning of the
experiment, were used in this study. Eight different
experimental groups received 239PuO2 at different
dose levels with or without additional B(a)P
(2 x 5mg): the first three columns of Table I give
the number of animals in the respective groups,
together with the doses of the two compounds:
At the beginning of the experiment, rats were
exposed to an aerosol of 239PuO2 in a chamber
described elsewhere (Metivier et al., 1974). The
oxide was prepared by calcining plutonium
peroxide at 1000°C, grinding it, and reheating at
1000°C to obtain stoichiometric PuG2. The Count
Median Diameter (CMD) of the aerosol was
0.61um (a= 1.28). The initial lung burden (ILB)
was determined 1 week after inhalation by in vivo
X-ray counting of 239Pu daughter products with a
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proportional counter. The radiation doses were
expressed as smeared doses (McClellan, 1972),
assuming 2g for fresh lung weights and 170 days
for half-time clearance, as observed earlier for this
strain (Metivier et al., 1977).
Two and 3 weeks after PuO2 inhalation, two
doses of 5mg B(a)P (ICN, K & K, Plainview, NY,
USA) were given by intratracheal instillation in
0.2ml saline solution. The solution was prepared by
grinding together equal amounts of B(a)P. and ferric
oxide, according to the method of Saffiotti et al.,
(1972a). Animals were anaesthetized before
treatment with 0.5-4% methoxyflurane (penthrane-
Abott) using a Minerve-Vaporizer with a gas-flow
mixture of 1 1min-1 nitrous oxide and 0.5 1min-1
oxygen. Animals receiving no B(a)P (groups 1 to 4)
were similarly injected with the vehicle alone. After
exposure, the animals were kept in stainless-steel
cages, five or six animals per cage, and given
standard diet (UAR, France) and water ad libitum.
All animals were inspected daily, killed when
moribund or observed until death. Autopsies of all
rats were performed immediately after death.
Whole lungs and any tissue that appeared to be
abnormal were fixed in Bouin Hollande fluid, then
embedded in paraffin. The pathological
classification of lung cancers was established
according to histological criteria described
elsewhere (Masse, 1980; Pour et al., 1976),
malignant tumours being considered the major end-
point of this experiment. Context of observation
"incidental'. or "fatal" was also recorded (Peto et
al., 1980); consideration was given to tumour
weight, size and precise location, so that the context
of observation of some small but malignant
tumours was classified as incidental.
Statistical methods
The context of observation of the lung tumours was
taken into consideration in the statistical analysis of
the results, using methods proposed by Peto et al.
(1980). For tumours observed in a fatal context,
"death rate methods" were used to calculate
observed (0) and expected (E) numbers of tumours
in the experimental groups under comparison. For
tumours found in an incidental context, the
"prevalence rate method" was used to derive O's
and E's, and these were combined with the
respective O's and E's from the "death-rate"
analysis for an overall analysis.
In view of the two-factorial design of this
experiment, the effect of a single factor at each
fixed level of the other factor was investigated. The
effect of one factor was averaged over the levels of
the other factor by summing the corresponding O's
and E's. Ratios of the specific O/E ratios yielded
relative risk estimates for different levels of the one
factor studied in this way.
In order to investigate the nature of the joint
action of the two exposures, relative risks were also
calculated by comparing the tumour yields in the
groups with joint exposures to those in the baseline
group.
Survival times were described by group medians
and respective 95% confidence intervals.
Results
Median survival times of all eight groups are given
in Table I. Exposure to B(a)P reduced survival time
considerably in conjunction with the first three
levels of PuO2 exposure (0, 222 and 630 Bq),
whereas with the highest dose of BuO2 no further
decrease was noted. With or without additional
B(a)P exposure, survival was longest without
exposure to PuO2, being about equal for animals
exposed to the low and median dose of PuO2 and
considerably lower in those at the highest PuO2
dose.
The induced tumours were mainly well-
differentiated keratinizing squamous-cell car-
cinomas. All of them exhibited large areas with
Table I Summary of protocols of PuO2-B(a)P inhalation experiments
No. ofanimals
Median
survival time Median With pulmonary
PuO2 (95% confidence) life-time malignancies
Group No. of initial lung B(a)P interval) dose Withfatal
number animals burden (Bq) (mg) (days) (Gy) Fatal Incidental benign tumours
1 89 0 0 864 (822-898) 0.0 0 0 0
2 89 220 0 820 (763-852) 3.3 4 13 0
3 30 630 0 798 (664-855) 9.4 6 8 0
4 19 6300 0 345 (235-428) 76.3 1 5 0
5 38 0 2 x 5 675 (543-760) 0 7 3 2
6 29 220 2 x 5 444 (338-486) 2.9 15 2 10
7 22 630 2 x 5 480 (335-704) 8.5 14 2 0
8 19 6300 2x5 330(264-439) 75.4 18 1 0JOINT CARCINOGENICITY OF PuO2 AND B(a)P 217
strongly pleomorphic nuclei. Invasion of the pleura
and mediastinal space was consistently observed;
occasional clusters of tumour cells were seen in
lymphatic channels, although peritracheal node
invasion was much less frequent. Heavy deposits of
haematite were conspicuous in the lung and in the
nodes; the latter often appeared dilated with lymph
and were hypophasic in both cortical and
paracortical areas.
Incidental broncholoalveolar adenomas were also
observed in some animals (2% in all treated
groups).
Inflammatory reactions occurred consistently in
all tumour-bearing lungs.
In Table II, the results of investigations of the
effect of PuO2 are shown. The upper part of the
table gives the results of a comparison of groups 1-
4 (without B(a)P); the central part, groups 5-8
(with B(a)P; and, finally, the two analyses are
summed to yield a summary of the overall effect of
PuG2. Test statistics for positive trend were
calculated using scores 0, 1, 2 and 3 for the
different levels of PuO2 exposure.
For tumours found in either a fatal or incidental
context, with or without additional B(a)P exposure
there was a clearly increasing tumour incidence
with increasing PuO2 dose. A notable difference
with additional B(a)P exposure is that the trend for
fatal tumours became even more pronounced,
whereas for incidental tumours the significance was
reduced, although only slightly. As with the
survival times, the differences in tumour incidences
between the low and median dose levels of PuO2
are not very large.
A summary of the effect of PuO2 exposure may
be made in terms of the relative risks of the
exposed groups compared to the unexposed group.
By comparing the ratios of the O/E's from the
exposed groups to those of the unexposed group (in
the lower part of Table II), the relative risks for
tumours found in a fatal context are 5.1, 6.7 and
15.3 for exposure to 220, 630 and 6300 Bq,
respectively; for total tumour incidence, the
respective relative risks are 5.9, 8.4 and 15.8.
The corresponding analysis of the effect of B(a)P
is reported in Table III. At all levels of PuO2
exposure, B(a)P led to a significant increase in the
incidence of tumours found in a fatal context and
as a consequence, an increase in total tumour
incidence. Tumours found in an incidental context
are elevated only when no PuO2 was administered.
This finding is in agreement with the observation
made above that B(a)P, besides increasing the total
tumour yield, increases the likelihood of finding
tumours in a fatal context.
In the lower part of Table III, which reports the
effect of B(a)P adjusted over the different levels of
Pu02, the O/E from the 2 x 5mg B(a)P column
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Table III Effect of B(a)P with various levels of PuO2 and adjusted over those levels
B(a)P
0 2x5 mg
Pu02
(Bq) 0 E O/E 0 E O/E Z P
f1* 0 5.34 0.00 7 1.66 4.21 4.79 <0.001
0 i 0 2.57 0.00 3 0.43 6.92 4.39 <0.001
t 0 7.91 0.00 10 2.09 4.77 6.29 <0.001
f 4 16.61 0.24 15 2.39 6.29 9.01 <0.001
220 i 13 13.78 0.94 2 1.22 1.64 0.83 NS
t 17 30.40 0.56 17 3.60 4.72 7.93 <0.001
f 6 14.23 0.42 14 5.77 2.43 4.23 <0.001
630 i 8 7.08 1.13 2 2.92 0.69 -0.82 NS
t 14 21.31 0.66 16 8.69 1.84 3.25 <0.001
f 1 8.56 0.11 18 10.04 1.79 3.71 <0.001
6300 i 5 5.50 0.91 1 0.50 2.00 1.00 NS
t 6 14.46 0.41 19 10.54 1.80 3.84 <0.001
Adjusted f 11 45.14 0.24 54 19.86 2.72 9.19 <0.001
over i 26 28.93 0.90 8 5.07 1.58 1.41 NS
Pu02 t 37 74.08 0.50 62 24.92 2.49 8.59 <0.001
levels
*For abbreviations see legend to Table II.
may be divided by the O/E from the column in
which the groups unexposed to B(a)P are reported
to give adjusted estimates of the relative risk of the
B(a)P exposure. For fatal tumours, the relative risk
is 2.72/0.24=11.3; whereas for total tumour
incidence, it is 5.0.
In addition to the malignant tumours reported
above, large benign tumours (squamous cell
papillomas) leading to the death of the animal were
observed in two experimental groups, as indicated
in Table I. Of the two animals with such lesions in
group 5, neither had a malignant tumour, whereas
two of the respective 10 animals in group 6 also
had a fatal malignancy and one an incidental
malignancy. These tumours were not included in
the formal statistical analyses but are discussed
later.
The method of describing the effect of certain
exposures in terms of relative risks, whereby
differences in longevity are adjusted for, can lead to
a simple investigation of the joint effect of two
exposures. For this, one has to calculate the relative
risks of the groups receiving non-zero levels of both
exposures compared individually with the
unexposed control group.
In our example, this would not be very
informative since no tumours at all were observed
in the unexposed control animals (group 1), which,
in turn, would make any estimate of the relative
risk, infinity. However, as the aim of this study was
to investigate the additive role of B(a)P with some
PuO2 exposure, only those groups that received
some dose of PuO2 (groups 2, 3, 4, 6, 7 and 8 of
Table I) were considered. Furthermore, the lowest
exposure to PuO2 (220 Bq) represents a low-level
exposure that is closer to background exposures at
workplaces. Therefore, group 2 was considered as
the baseline group on which to base the relative
risks. In Table IV, we report relative risks for total
tumour incidence and for fatal tumours derived by
comparing the groups 3, 4, 6, 7 and 8 with group 2.
The relative risks in the margins of this table are
derived in the same way as those in Tables II and
III, the only difference being that groups 1 and 5
were not included.
The measures of the effect of one factor adjusted
for the other factor (Tables II, III and IV) were
obtained under the assumption that they are equal
at all levels of the factor adjusted for, i.e., the
relative risk due to B(a)P does not depend on
PuG2, while the relative risks for PuO2 are
independent of B(a)P (Breslow & Day, 1980). Thus,
the "adjusted" relative risks in Table IV are
calculated on the basis of the hypothesis of
multiplicative action, i.e., that the joint effect of
PuO2 and B(a)P is the product of the individual
effects.
Smooth estimates of the relative risks in groups
with both exposures can be obtained by multiplying
the respective adjusted values. For example, the
relative risk for total tumour yield of the group
exposed to 630Bq PuO2 and 2 x 5mg B(a)P can beJOINT CARCINOGENICITY OF PuO2 AND B(a)P 219
Table IV Relative risks for total tumour incidence and for fatal tumours (in parentheses) compared
to experimental group 2 (see text).
PuO2(Bq)
Adjusted
220 630 6300 for PuO2
B(a)P 0 1.0 3.0 (5.1) 2.9 (11.8) 1.0
(mg) 2 x 5 8.4 (26.2) 8.9 (24.3) 18.8 (46.7) 4.1 (9.3)
Adjusted
for B(a)P 1.0 1.4 (1.3) 3.0 (3.2)
estimated, on the basis of the hypothesis of
multiplicative action, to be 1.4 x 4.1 =5.7, compared
with the group-specific estimate of 8.9. It can be
seen that all the group-specific relative risks, except
that for total tumour incidence in the 6300Bq PuO2
group without B(a)P, are higher than those
predicted by such a multiplicative model; this is
particularly true if only the fatal tumours are
considered.
Discussion
This study confirms, first of all, the well-established
potential of PuO2 and B(a)P to induce pulmonary
tumours. Consequently, we shall concentrate our
discussion on the exploration of the joint effect of
these two exposures.
Analysis of studies on pulmonary carcinogenesis
induced by inhaled radioactive substances has been
fraught with problems inherent in accounting
properly for differences in mortality in different
experimental groups (Chmelevsky et al., 1982). This
would also be a problem if the raw data reported in
Table I were used to assess the effect of the two
exposures under consideration. This problem of
difference in mortality has also been noted in the
field of chemical carcinogenesis, and recom-
mendations for its solution have been made (Peto,
1974; Gart et al., 1979).
For an unbiased statistical analysis of tumour
incidence data, it is also necessary to distinguish
whether a tumour is found in a fatal or an
incidental context. The analysis of our complex
experiment with radioactive as well as chemical
exposure should therefore also provide empirical
evidence about the usefulness of this concept for
the investigation ofpulmonary carcinogenesis.
The distinction between tumours observed in a
fatal and in an incidental context was occasionally
complicated by the occurrence of some benign but
fatal tumours. For animals with malignant tumours
only, the context of observation of these tumours
could be determined easily using the tumour mass
as the major criterion. It has been argued that even
small tumours may be fatal by specific secretions
(Burnett, 1964); however, experiments in which
tumours induced in one animal were grafted to
Wistar rats did not support this hypothesis for this
kind of tumour (Nolibe et al., 1976). The context of
observation of the malignant tumours that were
observed in the three animals that also had a large
benign tumour was assessed as if the benign
tumours were not present, and the benign tumours
were not taken into consideration in the reported
analyses, since they appear not to represent a
genuine carcinogenic risk.
As indicated in the "Introduction", the
carcinogenic potential of PuO2 and B(a)P is well
established, and was demonstrated again in this
experiment. The shortened survival times of animals
exposed to the higher dose levels of PuO2 (Table I)
made it obvious that an analysis adjusted for
intercurrent mortality had to be employed.
The pattern of the O/E's in Tables II and III,
together with the relative risks derived from them,
give a good indication of the effects of PuO2 or
B(a)P alone. The description of these effects was
facilitated by the distinction of tumours into a fatal
or an incidental context. It can be seen clearly that
the additional B(a)P exposure resulted not only in
an overall increase in tumour yield but was also
accompanied by an increased fatality of the lesions.
The major purpose of this study, however, was to
investigate the joint effect of a radioactive and a
chemical exposure on lung tumour risk. To this
end, a description of the observed effects in terms
of relative risks derived after adjustment for
differences in mortality was adopted. In this
framework, so-called additive or multiplicative
models have been used which comport different
biological and public health implications.
The results presented in Table IV show clearly
that the carcinogenic risk ofjoint exposure to PuO2
and B(a)P is at least the product of the individual
risks. An excess above the multiplicative model
appears to be even more pronounced for tumours
found in a fatal context. This reasoning, however,
does not represent a full-scale fitting of statistical
models: methods that would take into account fatal220 H. METIVIER et al.
and incidental tumours and adjust for differences in
mortality are not available. The problem in
describing the observed incidences in terms of
relative risks and investigating whether
multiplicativity is fulfilled is that the individual
relative risks, all of which refer to one baseline
group, may contain considerable random error.
However, the product of the respective relative risks
in the margins of Table IV appears to be an
underestimate of the group-specific relative risk.
This led us to conclude that if the data did not fit
an appropriate multiplicative model it was more
likely that the true model would describe an excess
over multiplicativity. Since in additive models the
relative risks of the joint exposure categories are
well below those predicted by a multiplicative
model, we consider that the data reported in Table
IV justify the conclusion that a multiplicative model
is definitely more likely to describe the data than an
additive model.
An assessment of the joint effect of two
exposures in carcinogenesis experiments, such as the
one reported here, requires careful consideration of
the measure by which the effects are expressed.
Relative risks appear to be easily applicable, and
understandable parameters and models formulated
in terms of relative risks have not only some
biological basis but are also understood both in
experimental and epidemiological research on the
aetiology of chronic diseases. In addition, it is
extremely important to use methods in which
adjustment is made for intercurrent mortality. For
example, crude rates from the joint exposure groups
may underreprescile lie true carcinogenic effect and
could thus suppoir tlic wrong conclusion that an
additive model bascd on these crude rates holds.
The biological implications of a multiplicative
model could be that each exposure acts at a
different stage of the multistage process of
carcinogenesis (Peto, 1977), as with asbestos and
smoking, for example (Saracci, 1977). In terms of
public health considerations, such multiplicative
effects must be viewed as synergistic effects (Blot &
Day, 1979). In such situations, the removal of one
exposure could considerably reduce the risk, as a
large fraction of the synergistic effect would be
removed as well (Saracci, 1981).
The relative risks of PuO2 exposure shown in
Table IV were derived in comparison with the low
dose level (220Bq) of PuO2. Such levels may
represent accidentally increased risks of
occupational populations; if in addition, one
considers the observed effect of B(a)P exposure to
represent possible risks of smoking, the remarks
made above concerning the beneficial effect of
removing one exposure in a situation in which the
multiplicative model holds become very pertinent.
For example, the removal of PuO2 deposits from
lungs by lavage (Nolibe et al., 1977) or alteration of
smoking habits of occupational groups potentially
exposed to radioactive substances would appear to
be appropriate.
This work was carried out with the technical assistance of
I. L'Hullier, E. Aumaitre, M. Discour, G. Rateau and X.
Nguyen-Dinh, which the authors gratefully acknowledge.
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